JournalsHub
.online
Find My Journal
ML

Matthew LaBella

Myriad (Germany) DE

ORCID iD 0000-0002-3415-1101
7
Publications
464
Citations
3
H-Index
3
i10-Index
2.2
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Random and targeted transgene insertion in Caenorhabditis elegans using a modified Mos1 transposon OA
Christian Frøkjær‐Jensen, M. Wayne Davis, Mihail Sarov, Jon Taylor, Stéphane Flibotte +4 more
Nature Methods 2014
424
Casein Kinase 1δ Stabilizes Mature Axons by Inhibiting Transcription Termination of Ankyrin OA
Matthew LaBella, Edward J. Hujber, Kristin A. Moore, Randi L. Rawson, Sean A. Merrill +5 more
Developmental Cell 2020
29
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial
Chad Tang, Alexander D. Sherry, Aaron Seo, Kieko Hara, Haesun Choi +25 more
The Lancet Oncology 2025
10
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model
Tu Sm, Aaron Seo, Alexander D. Sherry, Peng Yang, Kieko Hara +22 more
European Urology 2026
1

Publications

7 total

KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model

Tu Sm, Aaron Seo, Alexander D. Sherry, Peng Yang, Kieko Hara et al. - European Urology, 2026
Cited by 1 OpenAlex

Abstract 5313: Fragmentomic analysis of cfDNA WGS at regulatory regions generates gene-level expression-like traits for subtype analysis in breast cancer.

Jonathan Shepherd, Jeff Burdine, Yoichiro Shibata, Gregory M. Mayhew, Gabe Milburn et al. - Cancer Research, 2026
Cited by 0 OpenAlex

Abstract CT172: A phase II trial of adjuvant PD-1 blockade with endocrine therapy in hormone receptor positive inflammatory breast cancer: Circulating biomarkers and molecular correlates of clinical outcomes

Ranjan Upadhyay, Angela Alexander, Qing Ye, K Chen, John M. Elizarraras et al. - Cancer Research, 2026
Cited by 0 OpenAlex

Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial

Chad Tang, Alexander D. Sherry, Aaron Seo, Kieko Hara, Haesun Choi et al. - The Lancet Oncology, 2025
Cited by 10 OpenAlex

Abstract 6641: Inclusion of INDEL somatic variants in MRD panels improves confidence in ctDNA residual disease detection

Ravi B. Patel, Elise Buser, Nafei Xu, Matthew LaBella, Kyle Trettin et al. - Cancer Research, 2025
Cited by 0 OpenAlex

Casein Kinase 1δ Stabilizes Mature Axons by Inhibiting Transcription Termination of Ankyrin PDF

Matthew LaBella, Edward J. Hujber, Kristin A. Moore, Randi L. Rawson, Sean A. Merrill et al. - Developmental Cell, 2020
Cited by 29 OpenAlex

Random and targeted transgene insertion in Caenorhabditis elegans using a modified Mos1 transposon PDF

Christian Frøkjær‐Jensen, M. Wayne Davis, Mihail Sarov, Jon Taylor, Stéphane Flibotte et al. - Nature Methods, 2014
Cited by 424 OpenAlex

Research Topics

Renal cell carcinoma treatment (2) Cancer Genomics and Diagnostics (2) Cancer Immunotherapy and Biomarkers (1) Breast Cancer Treatment Studies (1) Thyroid Cancer Diagnosis and Treatment (1)

Frequent Co-Authors

C.
C.J. Battey
3 joint publications
AS
Ashley Acevedo
3 joint publications
ER
Erik M. Jørgensen
2 joint publications
AL
Alexander D. Sherry
2 joint publications
CR
Craig A. Kovitz
2 joint publications
SH
Shiqin Su
2 joint publications

Affiliations

Howard Hughes Medical Institute
US 2020 - 2020
Myriad (Germany)
DE 2026 - 2026
University of Utah
US 2020 - 2014
Myriad Genetics
US 2026 - 2025

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now